Literature DB >> 4096529

Detection of complement activation in human serum using C5a-induced chemiluminescence of human granulocytes.

A Kapp, F E Maly, E Schöpf.   

Abstract

The complement system can be activated by many factors, including immune complexes, leading to the generation of biologically active split products like C5a anaphylatoxin. This study presents a technique which may be used for measuring C5a activity in human serum. The tetanus-anti-tetanus immune complex and aggregated human IgG were used as model activators of the complement cascade. The C5a activity was measured by C5a-induced chemiluminescence of granulocytes; furthermore, a radioimmunoassay was used to detect the C5a peptide. There was a strongly positive correlation between the two assay systems. The described method should be useful as an alternative means of detecting complement activation in the serum of patients with inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4096529     DOI: 10.1007/BF00412494

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  9 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema.

Authors:  R J Ziccardi; N R Cooper
Journal:  Clin Immunol Immunopathol       Date:  1980-03

Review 3.  The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.

Authors:  T E Hugli
Journal:  Crit Rev Immunol       Date:  1981-02       Impact factor: 2.214

4.  Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.

Authors:  D E Hammerschmidt; T K Bowers; C J Lammi-Keefe; H S Jacob; P R Craddock
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

5.  Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.

Authors:  J L Wagner; T E Hugli
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

6.  C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor.

Authors:  F E Maly; A Kapp; U Rother
Journal:  Immunobiology       Date:  1983-02       Impact factor: 3.144

7.  Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.

Authors:  W O Weigle; E L Morgan; M G Goodman; D E Chenoweth; T E Hugli
Journal:  Fed Proc       Date:  1982-12

8.  Immune complexes: characteristics, clinical correlations, and interpretive approaches in the clinical laboratory.

Authors:  S E Ritzmann; J C Daniels
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

9.  Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.

Authors:  M G Goodman; D E Chenoweth; W O Weigle
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Modulation of granulocyte oxidative response by recombinant interferon alpha 2 and gamma.

Authors:  A Kapp; H Kirchner; H Wokalek; E Schöpf
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Interaction between human neutrophils and corneocytes: corneocyte-induced respiratory burst of neutrophils assessed by chemiluminescence.

Authors:  T Kato; M Hara; O Iizawa; T Terui; H Tagami
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

3.  Inhibitory effect of sulfonated shale oils (ammonium bituminosulfonate) on the stimulation of neutrophilic granulocytes by the chemotactic tripeptide f-Met-Leu-Phe.

Authors:  E Kownatzki; A Kapp; S Uhrich
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.